Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Justin Stebbing

Showing results (11-20 of 504) with videos related to

Pageof 51
Sort By:
The Lancet. Oncology|July 10, 2003
What can oncologists learn from HIV?Justin Stebbing, Mark Bower
The Lancet. Infectious Diseases|May 17, 2011
The HVTN 503/Phambili study: efficacy is always the issueZaneeta Dhesi, Justin Stebbing
The Lancet. Oncology|March 3, 2012
Ginger: the root of cancer therapy?Jonathan Krell, Justin Stebbing
The Lancet. Oncology|January 4, 2006
Comparative pharmacogenomics of antiretroviral and cytotoxic treatmentsJustin Stebbing, Mark Bower
Clinical Evidence|January 18, 2005
Breast cancer (metastatic)Justin Stebbing, Robert Glassman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2017
Geographic Variation in EGFR Mutation Frequency in Lung Adenocarcinoma May Be Explained by Interethnic Genetic VariationLars Soraas, Justin Stebbing
The Lancet. Infectious Diseases|April 28, 2009
Not so SMART?Justin Stebbing, Angus Dalgleish
The Lancet. Oncology|April 4, 2009
Epstein-Barr virus in Burkitt's lymphoma: the missing linkJustin Stebbing, Mark Bower
Pharmacogenomics|February 9, 2007
Heat shock protein-receptor-based pharmacogenomics: the search for new cancer antigensJustin Stebbing, Pramod Srivastava
Nature Clinical Practice. Oncology|December 22, 2006
Cytotoxic-free treatment designs: time to resistanceJustin Stebbing, Tim Crook
Pageof 51

Showing results (11-20 of 504) with videos related to

Sort By:
Pageof 51
The Lancet. Oncology|July 10, 2003
What can oncologists learn from HIV?Justin Stebbing, Mark Bower
The Lancet. Infectious Diseases|May 17, 2011
The HVTN 503/Phambili study: efficacy is always the issueZaneeta Dhesi, Justin Stebbing
The Lancet. Oncology|March 3, 2012
Ginger: the root of cancer therapy?Jonathan Krell, Justin Stebbing
The Lancet. Oncology|January 4, 2006
Comparative pharmacogenomics of antiretroviral and cytotoxic treatmentsJustin Stebbing, Mark Bower
Clinical Evidence|January 18, 2005
Breast cancer (metastatic)Justin Stebbing, Robert Glassman
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|December 17, 2017
Geographic Variation in EGFR Mutation Frequency in Lung Adenocarcinoma May Be Explained by Interethnic Genetic VariationLars Soraas, Justin Stebbing
The Lancet. Infectious Diseases|April 28, 2009
Not so SMART?Justin Stebbing, Angus Dalgleish
The Lancet. Oncology|April 4, 2009
Epstein-Barr virus in Burkitt's lymphoma: the missing linkJustin Stebbing, Mark Bower
Pharmacogenomics|February 9, 2007
Heat shock protein-receptor-based pharmacogenomics: the search for new cancer antigensJustin Stebbing, Pramod Srivastava
Nature Clinical Practice. Oncology|December 22, 2006
Cytotoxic-free treatment designs: time to resistanceJustin Stebbing, Tim Crook
Pageof 51